Andrew Freeman

Dr. Andrew Freeman is a Research Fellow in the Department of Anatomy & Developmental Biology at Monash University. His research focuses on cancer immunotherapy mechanisms, tumor immune evasion, and cytokine signaling pathways. He leads a major 2026-2030 project investigating mesenchymal stromal cells' therapeutic potential. Freeman holds prestigious awards including the 2024 Early Career Postdoctoral Fellowship and multiple scholarships (2015-2018).

His work bridges immunology and oncology, with key contributions in TNF cytotoxicity modulation, CAR T-cell optimization, and autophagy inhibition strategies. He has collaborated extensively across disciplines, evidenced by 10+ peer-reviewed publications and patent-referenced research. Freeman's current investigations aim to enhance cancer therapies through mechanistic understanding of immune evasion pathways.